The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3180-3184

  Nilsson, Gunnar ^a   Skytting, Björn ^b   Xie, Yuntao ^a   Brodin, Bertha ^a,c   Perfekt, Roland ^d   Mandahl, Nils ^d   Lundeberg, Joakim ^c   Uhlén, Mathias ^c   Larsson, Olle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CHROMOSOME 18; CLINICAL ARTICLE; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEQUENCE ANALYSIS; SYNOVIAL SARCOMA; TUMOR GROWTH; X CHROMOSOME;

EID: 0033168038     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Enzinger, F. M., and Weiss, S. W. Soft Tissue Tumors, 3rd ed. St. Louis, MO: Mosby, 1995.
2. Meis-Kindblom, J. M., Stenman, G., and Kindblom, L-G. Differential diagnosis of small round cell tumors. Semin. Diagn. Pathol., 13: 213-241, 1996.
3. Turc-Carel, C., Dal Cin, P., Limon, J., Rao, U., Li, F. P., Corson, J. M., Zimmerman, R., Parry, D. M., Cowan, J. M., and Sandberg, A. A. Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc. Natl. Acad. Sci. USA, 84: 1981-1985, 1987.
4. Clark, J., Rocques, P. J., Crew, A. J., Gill, S., Shipley, J., Chan, A. M., Gusterson, B. A., and Cooper, C. S. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat. Genet., 7: 502-508, 1994.
5. Crew, J., Clark, J., Fisher, C., Gill, S., Grimer, R., and Mitchell, P. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J., 14: 2333-2340, 1995.
6. de Leeuw, B., Balemans, M., Olde Weghuis, D., and Geurts van Kessel, A. Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2; q11.2)-positive synovial sarcomas. Hum. Mol. Genet., 4: 1097-1099, 1995.
7. de Leeuw, B., Balemans, M., and Geurts van Kessel, A. A novel Krüppel-associated box containing the SSX gene (SSX3) on the human X chromosome is not implicated in t(X;18)-positive synovial sarcomas. Cytogenet. Cell Genet., 73: 179-183, 1996.
8. Gure, A. O., Tureci, O., Sahin, U., Tsang, S., Scanlan, M. J., Jager, E., Knuth, A., Pfreundschuh, M., Old, L. J., and Chen, Y-T. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int. J. Cancer, 72: 965-971, 1997.
9. Brett, D., Whitehouse, S., Antonson, P., Shipley, J., Cooper, C., and Goodwin, G. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum. Mol. Genet., 6: 1559-1564, 1997.
10. Lim, F. L., Soulez, M., Koczan, D., Thiesen, H-J., and Knight, J. C. A KRAB-related domain and a novel transcription repressor domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene, 17: 2013-2018, 1998.
11. Hajdu, S. I., Shiu, M. H., and Fortner, J. G. Tendosynovial sarcoma: a clinicopathological study of 136 cases. Cancer (Phila.), 39: 1201-1217, 1977.
12. Brodsky, J. T., Burt, M. E., Hajdu, S. I., Casper, E. S., and Brennan, M. F. Tendosynovial sarcoma. Clinicopathologic features, treatment, and prognosis. Cancer (Phila.), 70: 484-489, 1992.
13. Skytting, B. T., Bauer, H. C., Perfekt, R., Nilsson, G., and Larsson, O. Ki-67 is strongly prognostic in synovial sarcoma. Analysis based on 86 patients from the Scandinavian Sarcoma Group Register. Br. J. Cancer, in press, 1999.
14. Kawai, A., Woodruff, J., Healey, J. H., Brennan, M. F., Antonescu, C. R., and Ladanyi, M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N. Engl. J. Med., 338: 153-160, 1998.
15. Broders, A. C., and Hargrave, R. Pathologic features of soft tissue fibrosarcoma. Surg. Gynecol. Obstet., 69: 267-280, 1939.
16. Angervall, L., Kindblom, L. G., Rydholm, A., and Stener, B. The diagnosis and prognosis of soft tissue tumors. Semin. Diagn. Pathol., 3: 240-258, 1986.
17. Fligman, I., Lonardo, F., Jhanwar, S. C., Gerald, W. L., Woodruff, J., and Ladanyi, M. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am. J. Pathol., 147: 1592-1599, 1995.
18. Choong, P. F., Åkerman, M., Willen, H., Andersson, C., Gustafson, P., Baldetorp, B., Fernö, M., Alvegård, T., and Rydholm, A. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation - a marker of metastasis? Acta Pathologica Microbiologica Immunologica Scandinavica, 102: 915-924, 1994.
19. Bergh, P., Meis-Kindblom, J. M., Gherlinzoni, F., Berlin, Ö., Bacchini, P., Bertoni, F., Gunterberg, B., and Kindblom, L-G. Synovial sarcoma: identification of high and low risk groups. Cancer (Phila.), in press, 1999.
20. Szymanska, J., Serra, M., Skytting, B., Larsson, O., Virolainen, M., Åkerman, M., Tarkkanen, M., Huuhtanen, R., Picci, P., Bacchini, P., Asko-Seljavaara, S., Elomaa, I., and Knuutila, S. Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer, 23: 213-219, 1998.
21. Wright, P. H., Sim, F. H., Soule, E. H., and Taylor, W. F. Synovial sarcoma. J. Bone Joint Surg. (Am.), 64: 112-122, 1982.
22. Choong, P. F., Åkerman, M., Willén, H., Andersson, C., Gustafson, P., Alvegåard, T., and Rydholm, A. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific? APMIS, 103: 797-805, 1995.
23. de Leeuw, B., Balemans, M., Olde Weghuis, D., Seruca, R., Janz, M., Geraghty, M. T., Gilgenkrantz, S., Ropers, H. H., and Geurts van Kessel, A. Molecular cloning of the synovial sarcoma-specific translocation (X;18)(p11.2:q11.2) breakpoint. Hum. Mol. Genet., 3: 745-749, 1994.
24. Janz, M., de Leeuw, B., Olde Weghuis, D., Werner, M., Nolte, M., Geurts Van Kessel, A., Nordheim, A., and Hipskind, R. A. Interphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma. J. Pathol., 175: 391-396, 1995.
25. Renwick, P. J., Reeves, B. R., Dal Cin, P., Fletcher, C. D., Kempski, H., Sciot, R., Kazmierczak, B., Jani, K., Sonobe, H., and Knight, J. C. Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for the histologic sub-classification of synovial sarcoma. Cytogenet. Cell Genet., 70: 58-63, 1995.